Latest Research Report on Nanomedicine
Market begins with a deep
introduction and then delves broad into specific segments such as raw material,
application, end user, and region, policy study, value chain structure, and
upcoming trends in particular segments or regions. The report on Nanomedicine prepare
a case for investments in different regions based on a practical view of their
regulatory outline, manufacturing dynamics, and availability of skills and
resources in that region.
Nanomedicine Market Report
by Material, Application, and Geography – Global Forecast to 2025 is a
professional and in-depth research report on the world’s major regional Nanomedicine
Market conditions, focusing on the main regions (North America, Europe and
Asia-Pacific) and the main countries (United States, Germany, united Kingdom,
Japan, South Korea and China).
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/nanomedicine-market/request-sample
Industry Insights
The global nanomedicine
market size was worth USD 138.9 billion in 2016 which is anticipated to grow at
a CAGR of more than 9.8% during the forecast period. Factors such as
technological advancements along with significant applications in the
prophylaxis of acute and chronic diseases, prevention intervention, and early
disease diagnosis are accountable for progress of this industry.
Miniaturization of bigger chemicals and structures at nanometric scale enables
the modernization in drug administration thus leading to growth in
nanotechnology market for healthcare industry.
Advancements in
nanorobotics due to the escalation in funding from the government bodies are
accountable to persuade potential to the nanomedicine market. Moreover,
nanorobotics engineering projects which are targeting only the cancer cells
without affecting the contiguous tissues is expected to promote progress
through to 2025.
Factors such as the
capability of nanotechnology to assist in both therapeutic and diagnostics
sector simultaneously are accountable for a large number of researches which
are undergoing in this sector. Moreover, application of DNA origami in the
healthcare is accountable for the projected CAGR.
Furthermore, pipeline
products based on the nano-molecules and related technologies are expected to
promote the progress over the forecast period. Other factors such as, presence
of number of products in phase II trial of clinical development and
personalized treatment option is also available which is accountable for the
development of nanotechnology for health care in the coming years.
Application Insights
Based on application, the
segment incorporates cardiology, infectious diseases, oncology, and other
applications. In 2016, oncology segment dominated with approximately 47%
revenue share.
Rise in the R&D and
funding activities in this segment is attributive for the larger share of this
segment. Moreover, continuous increase in the incidence of oncology diseases is
attributive for the development of nanotechnology based products for cancer
eradication.
Cardiology is expected to
witness fastest growth as a result of higher demand in the projected period due
to several opportunities such as implants for tissue regeneration,
nanostructured stents, and therapeutic nano-vectors.
Nanomolecule Type Insights
The capability of
nanoparticles to get linked with the chemical moieties in different forms such
as scaffolds aids in performing different functions. Moreover, application of
nanoparticles for active targeting by linking it to cell receptor’s ligands is
expected to drive progress potentially nanotechnology.
Metal and metal oxide is
expected to witness substantial demand due to its widespread utilization in
diagnostics. These nanoparticles enable diagnosis through the unique properties
of different metals and metal oxides.
Dendrimers and the
inorganic nanoparticles are also anticipated to grow at a potential rate in the
coming years as consequence of research carried out in these segments.
Furthermore, rising inclination of physicians towards nanodevices for
monitoring and prognosis is anticipated to boost demand in the coming years.
Regional Insights
The nanomedicine market was
dominated by North America with over 42% of revenue share due to escalating
partnerships between nanomedicine startups and enterprises. Moreover,
assistance from government organizations along with higher R&D expenditure
is accountable for the largest share of the province in this sector.
Asia Pacific is anticipated
to witness fruitful growth owing to factors such as rising demand for
prophylaxis of life-threatening diseases and increase in a number of research
grants. The escalation in a number of venture capital financiers and rising
international research associations are expected to promote the nanomedicine
growth in this region.
Competitive Insights
Several vital players are
functioning in this market such as Teva Pharmaceutical Industries Ltd,
Nanosphere, Inc., Celegene Corporation, Ablynx NV, GE Healthcare, Arrowhead
Research, and Combimatrix Corp. These players are engaged in attaining the U.S.
FDA approvals in order to enhance their revenue share.
Rising penetration of the
companies in diverse segments with respect to nanotechnology in order to
replace the conventional options of treatment and diagnosis is anticipated to
lead in growth in the coming years. Market entities are engaged in
collaborations with research institution and academic organizations in order to
carry out active research.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment